Results 71 to 80 of about 731 (139)

Safety of fluralaner chewable tablets (BravectoTM), a novel systemic antiparasitic drug, in dogs after oral administration

Parasites & Vectors, 2014
Background Fluralaner is a novel systemic insecticide and acaricide that provides long acting efficacy in dogs after a single oral treatment. This study investigated the safety of oral administration of fluralaner in chewable tablets to dogs at the ...
Feli M Walther, Mark J Allan, Rainer KA Roepke, Martin C Nuernberger   +3 more
doaj   +1 more source

Recent developments in fluorine‐containing pesticides

Pest Management Science, Volume 80, Issue 7, Page 3065-3087, July 2024.
In the timeframe 2016–2022, approximately 77% of the 39 launched products (herbicides, fungicides, insecticides, acaricides, and nematicides) were halogen‐substituted and from these, approximately 64% were fluorine‐containing pesticides. Abstract To ensure ongoing sustainability, the modern agrochemical industry is faced with enormous challenges. These
Peter Jeschke
wiley   +1 more source

Safety of fluralaner oral solution, a novel systemic poultry red mite treatment, for chicken breeders’ reproductive performances

Parasites & Vectors, 2017
Background Poultry mites are the most significant pest affecting production systems in the chicken egg-laying industry, altering the health condition of the birds, and causing stress, mortality and decline of egg quality impacting economic performance ...
Bruno Huyghe, Gaelle Le Traon, Annie Flochlay-Sigognault   +2 more
doaj   +1 more source

Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog

BMC Veterinary Research, 2019
Although the new isoxazoline drug fluralaner (Bravecto®) is generally well tolerated in dogs, adverse drug reactions involving neurological dysfunction occurred in individual dogs. However, most of these cases are documented inadequately and none of them is reported and discussed in the literature. As isoxazoline drugs target neuronal chloride channels
Gaens, Daniela, Rummel, Christoph, Schmidt, Martin, Hamann, Melanie, Geyer, Joachim, Justus Liebig University Giessen   +5 more
openaire   +4 more sources

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs

Parasites & Vectors, 2014
Background Fluralaner, a new molecular entity of the isoxazoline class, has potent insecticidal and acaricidal activity and can be safely administered orally to dogs.
Nadja Rohdich, Rainer KA Roepke, Eva Zschiesche   +2 more
doaj   +1 more source

A randomized controlled trial of the efficacy of orally administered fluralaner (Bravecto™) against induced Ixodes holocyclus (Australian paralysis tick) infestations on dogs

Parasites & Vectors, 2015
Background Ixodes holocyclus ticks are a frequently fatal threat to dogs in eastern Australia. These ticks secrete a neurotoxin that can produce an ascending paralysis after 72 h attachment that can lead to death in affected animals.
Petr Fisara, Maurice Webster
doaj   +1 more source

Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs

Parasites & Vectors, 2017
Background The clinical efficacy of fluralaner chewable tablets (Bravecto™, MSD Animal Health) against naturally acquired Linognathus setosus infestations on dogs was evaluated compared with permethrin (Exspot®, MSD Animal Health) treatment.
Heike Kohler-Aanesen, Seppo Saari, Rob Armstrong, Karine Péré, Janina Taenzler, Eva Zschiesche, Anja R Heckeroth   +6 more
doaj   +1 more source

A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus)

Parasites & Vectors, 2018
Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) was developed for the treatment of nematode infections as well as providing 12 weeks of protection against insect and acarine parasites in cats.
Nadja Rohdich, Eva Zschiesche, Oliver Wolf, Wolfgang Loehlein, Zvezdelina Kirkova, Petar Iliev, Dhimitër Rapti, Rezart Postoli, Balázs Capári, Róbert Farkas, Rainer K. A. Roepke   +10 more
doaj   +1 more source

A randomized, blinded, controlled trial to assess sand fly mortality of fluralaner administered orally in dogs

Parasites & Vectors, 2018
Background Leishmania infantum is the parasite responsible for the disease in humans known as zoonotic visceral leishmaniasis (ZVL). Dogs are considered the main domestic reservoir of ZVL and sand flies are the proven vectors.
Sonia Ares Gomez, Javier Lucientes, Juan Antonio Castillo, Maria Paz Peris, Sarah Delacour, Paula Ortega, Ronald-Vladimir Oropeza, Albert Picado   +7 more
doaj   +1 more source

Effectiveness of Fluralaner in Ticks Infesting Horses (Equus caballus)

Research Journal for Veterinary Practitioners, 2023
Camilo Romero Núñez, Galia Sheinberg Waisburd, Alberto Martin Cordero, Rafael Heredia Cárdenas, Laura Miranda Contreras, Ariadna Flores Ortega, Linda Guiliana Bautista Gómez   +6 more
openaire   +1 more source